Set and sold strategy and integrated European CRO acquisition target into global group, including leadership team, finance, reporting, and BD restructuring. Result: Highest ever contract backlog and double-digit growth during crisis year and improved profitability.
Established and restructured 100+ staff R&D centre for European pharma in India. Executive council member for top 50 pharma global R&D restructuring post M&A.
Designed and build competitive global clinical organization for top 50 pharma, responsible for 300 millUSD budget and 450 staff. Implemented benchmarking and performance improvement programs, more than doubling efficiency.
Dr. Hajos has a substantial network into C-level executives in Europe, US and India in pharma, biotech and service providers.
Total of 5 years as CEO, 8 years in CRO industry, 10 years in pharma. Previous companies: Merckle/Ratiopharm, Omnicare Clinical Research, Altana Pharma AG/ Nycomed, Ecron Acunova